99-7940. Manufacturer of Controlled Substances; Notice of Registration  

  • [Federal Register Volume 64, Number 62 (Thursday, April 1, 1999)]
    [Notices]
    [Page 15809]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 99-7940]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF JUSTICE
    
    Drug Enforcement Administration
    
    
    Manufacturer of Controlled Substances; Notice of Registration
    
        By Notice dated December 14, 1998, and published in the Federal 
    Register on December 23, 1998 (63 FR 71159), Noramco of Delaware, Inc., 
    Division of McNeilab, Inc., 500 Old Swedes Landing Road, Wilmington, 
    Delaware 19801, made application by renewal to the Drug Enforcement 
    Administration (DEA) to be registered as a bulk manufacturer of the 
    basic classes of controlled substances listed below:
    
    ------------------------------------------------------------------------
                        Drug                               Schedule
    ------------------------------------------------------------------------
    Codeine (9050).............................  II
    Oxycodone (9143)...........................  II
    Hydrocodone (9193).........................  II
    Morphine (9300)............................  II
    Thebaine (9333)............................  II
    ------------------------------------------------------------------------
    
        The firm plans to manufacture the listed controlled substances for 
    distribution to its customers as bulk product.
        DEA has considered the factors in Title 21, United States Code, 
    Section 823 (a) and determined that the registration of Noramco of 
    Delaware, Inc. to manufacture the listed controlled substances is 
    consistent with the public interest at this time. DEA has investigated 
    Noramco of Delaware, Inc. on a regular basis to ensure that the 
    company's continued registration is consistent with the public 
    interest. These investigations have included inspection and testing of 
    the company's physical security systems, audits of the company's 
    records, verification of the company's compliance with state and local 
    laws, and a review of the company's background and history. Therefore, 
    pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy 
    Assistant Administrator, Office of Diversion Control, hereby orders 
    that the application submitted by the above firm for registration as a 
    bulk manufacturer of the basic classes of controlled substances listed 
    above is granted.
    
        Dated: March 17, 1999.
    John H. King,
    Deputy Assistant Administrator, Office of Diversion Control, Drug 
    Enforcement Administration.
    [FR Doc. 99-7940 Filed 3-31-99; 8:45 am]
    BILLING CODE 4410-09-M
    
    
    

Document Information

Published:
04/01/1999
Department:
Drug Enforcement Administration
Entry Type:
Notice
Document Number:
99-7940
Pages:
15809-15809 (1 pages)
PDF File:
99-7940.pdf